Answer
The most frequently reported adverse reaction to Anoro Ellipta in patients with COPD is nasopharyngitis, reported in 9%.
Sources for this answer
- ANORO ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline UK · emc · SmPC §4.8 Undesirable effects · Version 17Document updated
Sources checked